OBJECTIVES: To assess the extent of drug resistance in Uige through molecular genetic analysis and to test whether the dhfr triple mutant alleles present in Angola are of southeast Asian origin. METHODS: Seventy-one samples of blood from children admitted to the Pediatric Emergency Unit of Uige Provincial Hospital in 2004 were screened for resistance mutations at pfcrt, pfmdr1, pfdhfr, pfdhps and pfATPase6. RESULTS: Mutations in pfcrt (codon76), pfmdr1 (codon86), pfdhfr (codons 51, 59, 108) and pfdhps (codons 436, 437) were common. Among the 66 isolates for which we were able to determine complete genetic information 13.7% carried all seven of these mutations. Flanking microsatellite analysis revealed the triple mutant pfdhfr was derived fr...
Purpose: Drug resistance is probably the greatest challenge to most malaria-control programmes. The ...
BACKGROUND: Although the molecular basis of resistance to a number of common antimalarial drugs is w...
Background: Sulphadoxine-pyrimethamine (SP) has been and is currently used for treatment of uncompli...
OBJECTIVESTo assess the extent of drug resistance in Uige through molecular genetic analysis and to ...
BACKGROUND: Resistance to the antimalarial drug sulfadoxine-pyrimethamine (SP) emerged in Plasmodium...
BACKGROUND: Sulfadoxine-pyrimethamine was first introduced for treatment of malaria in Africa during...
Background: Resistance to the antimalarial drug sulfadoxine-pyrimethamine (SP) emerged in Plasmodium...
Background: In response to chloroquine (CQ) resistance, the policy for the first-line treatment of u...
We have measured microsatellite diversity at 26 markers around the dhfr gene in pyrimethamine-sensit...
Background: In Tanzania, drug-resistant malaria parasites are an increasing public health concern. B...
Here we present molecular evidence demonstrating that malaria parasites bearing high-level pyrimetha...
BACKGROUND: Sulphadoxine-pyrimethamine (SP) resistance is now widespread throughout east and souther...
Malaria Journal 2011Background: Sulphadoxine-pyrimethamine (SP) resistance is now widespread through...
This thesis is a description of the effects of Sulphadoxine/Pyrimethamine (SP) selection on the geno...
BACKGROUND: Sulfadoxine-pyrimethamine (SP) is recommended for prophylactic treatment of malaria in p...
Purpose: Drug resistance is probably the greatest challenge to most malaria-control programmes. The ...
BACKGROUND: Although the molecular basis of resistance to a number of common antimalarial drugs is w...
Background: Sulphadoxine-pyrimethamine (SP) has been and is currently used for treatment of uncompli...
OBJECTIVESTo assess the extent of drug resistance in Uige through molecular genetic analysis and to ...
BACKGROUND: Resistance to the antimalarial drug sulfadoxine-pyrimethamine (SP) emerged in Plasmodium...
BACKGROUND: Sulfadoxine-pyrimethamine was first introduced for treatment of malaria in Africa during...
Background: Resistance to the antimalarial drug sulfadoxine-pyrimethamine (SP) emerged in Plasmodium...
Background: In response to chloroquine (CQ) resistance, the policy for the first-line treatment of u...
We have measured microsatellite diversity at 26 markers around the dhfr gene in pyrimethamine-sensit...
Background: In Tanzania, drug-resistant malaria parasites are an increasing public health concern. B...
Here we present molecular evidence demonstrating that malaria parasites bearing high-level pyrimetha...
BACKGROUND: Sulphadoxine-pyrimethamine (SP) resistance is now widespread throughout east and souther...
Malaria Journal 2011Background: Sulphadoxine-pyrimethamine (SP) resistance is now widespread through...
This thesis is a description of the effects of Sulphadoxine/Pyrimethamine (SP) selection on the geno...
BACKGROUND: Sulfadoxine-pyrimethamine (SP) is recommended for prophylactic treatment of malaria in p...
Purpose: Drug resistance is probably the greatest challenge to most malaria-control programmes. The ...
BACKGROUND: Although the molecular basis of resistance to a number of common antimalarial drugs is w...
Background: Sulphadoxine-pyrimethamine (SP) has been and is currently used for treatment of uncompli...